amifostine anhydrous has been researched along with Soft Tissue Neoplasms in 4 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Soft Tissue Neoplasms: Neoplasms of whatever cell type or origin, occurring in the extraskeletal connective tissue framework of the body including the organs of locomotion and their various component structures, such as nerves, blood vessels, lymphatics, etc.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The application of amifostine and sodium selenite to conventionally fractionated irradiation have no influence on the radiosensitivity of the rhabdomyosarcoma R1H." | 7.72 | The radioprotectors amifostine and sodium selenite do not modify the radiosensitivity of rat rhabdomyosarcomas. ( Metternich, FU; Sagowski, C; Tesche, S; Wenzel, S; Zywietz, F, 2004) |
| "The application of amifostine and sodium selenite to conventionally fractionated irradiation have no influence on the radiosensitivity of the rhabdomyosarcoma R1H." | 3.72 | The radioprotectors amifostine and sodium selenite do not modify the radiosensitivity of rat rhabdomyosarcomas. ( Metternich, FU; Sagowski, C; Tesche, S; Wenzel, S; Zywietz, F, 2004) |
| "Seventy-three dogs with soft tissue sarcomas were randomized to 2 dose response assays to receive irradiation alone or with the radioprotector WR-2721." | 2.66 | Influence of WR 2721 on radiation response of canine soft tissue sarcomas. ( Dewhirst, MW; Gillette, EL; McChesney, SL; Withrow, SJ, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sagowski, C | 2 |
| Tesche, S | 1 |
| Zywietz, F | 2 |
| Wenzel, S | 2 |
| Metternich, FU | 1 |
| Margulies, BS | 1 |
| Damron, TA | 1 |
| Allen, MJ | 1 |
| Neumann, B | 1 |
| Kehrl, W | 1 |
| Roeser, K | 1 |
| Ussmüller, J | 1 |
| McChesney, SL | 1 |
| Gillette, EL | 1 |
| Dewhirst, MW | 1 |
| Withrow, SJ | 1 |
1 trial available for amifostine anhydrous and Soft Tissue Neoplasms
| Article | Year |
|---|---|
Influence of WR 2721 on radiation response of canine soft tissue sarcomas.
Topics: Amifostine; Animals; Clinical Trials as Topic; Combined Modality Therapy; Dog Diseases; Dogs; Organo | 1986 |
3 other studies available for amifostine anhydrous and Soft Tissue Neoplasms
| Article | Year |
|---|---|
The radioprotectors amifostine and sodium selenite do not modify the radiosensitivity of rat rhabdomyosarcomas.
Topics: Amifostine; Animals; Cell Survival; Cobalt Radioisotopes; Dose Fractionation, Radiation; Injections, | 2004 |
The differential effects of the radioprotectant drugs amifostine and sodium selenite treatment in combination with radiation therapy on constituent bone cells, Ewing's sarcoma of bone tumor cells, and rhabdomyosarcoma tumor cells in vitro.
Topics: Amifostine; Animals; Bone Neoplasms; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitum | 2008 |
[Radioprotective effectiveness of amifostine on the salivary glands of the rat during fractionated irradiation].
Topics: Amifostine; Animals; Cobalt Radioisotopes; Dose Fractionation, Radiation; Male; Neoplasm Transplanta | 2002 |